American Society of Hematology

Press Releases

Subscribe to RSS
  • New study finds cellular immunotherapy treatment associated with improved quality of life Feb 19, 2020

    Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy showed marked improvement on a variety of self-reported quality of life measures, according to a study published today in Blood Advances. The study offers evidence that CAR-T may not only extend cancer patients’ survival, but also improve their quality of life after treatment.

  • Statement on New ASH Clinical Practice Guidelines on Sickle Cell Disease-Related Transfusion Support Jan 27, 2020

    Today, the American Society of Hematology (ASH) released new clinical practice guidelines on Sickle Cell Disease (SCD)-Related Transfusion Support. These guidelines are part of a series of five guidelines ASH is developing on SCD to provide updated treatment guidelines that reflect the newest evidence about the disease, ensuring the medical community can better treat SCD and people with SCD can make the best decisions for their care.

  • Minority Hematology Scholars to Study New Methods for Improving Blood Disease Treatments Jan 23, 2020

    The American Society of Hematology is pleased to announce that Gabriela Hobbs, MD, of Massachusetts General Hospital, and Oluwatoyosi Onwuemene, MD, MS, of Duke University have been selected to participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program, a partnership between ASH and the Robert Wood Johnson Foundation.

  • Stephanie Lee, MD, MPH, Begins Term as 2020 ASH President Jan 10, 2020

    Stephanie Lee, MD, MPH, a highly regarded expert in graft-versus-host disease as well as blood and bone marrow diseases, will serve as president of the American Society of Hematology for a year-long term through December 2020.

  • Metabolic syndrome associated with increased risk of blood clot recurrence Jan 09, 2020

    People with metabolic syndrome – a set of conditions including obesity, impaired glucose metabolism, elevated levels of fats and cholesterol in the blood, and high blood pressure – are more likely to experience recurrent blood clots, according to a new study published today in Blood Advances.

  • New Study Finds Blood Clots More Likely in Children Who Receive Peripherally Inserted Central Catheters Jan 07, 2020

    A new study provides convincing evidence that the use of peripherally inserted central catheters (PICCs) to administer medicine and draw blood in children is associated with a significantly increased risk of blood clots (known as venous thromboembolism or VTE) compared with central venous catheters (CVCs) placed directly into the neck or chest.

  • Statement from ASH President Stephanie Lee, MD, on Proposed Administration Policy to Change Open Access Peer Reviewed Journals Dec 19, 2019

    Yesterday, the American Society of Hematology (ASH) sent a letter to President Trump outlining concerns with a proposed policy that would jeopardize the intellectual property of American organizations engaged in the creation of high-quality peer-reviewed journals and research articles. The Administration is considering an Executive Order that would mandate that scientific articles reporting on federally funded research be made immediately available to everyone upon publication, eliminating or reducing the current 12-month embargo period that has been in place since 2008.


  • American Society of Hematology Announces 2020 Scholar Award Recipients Dec 19, 2019

    ASH today announced the 39 recipients of its 2020 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Awards financially support fellows to junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.

  • ASH President Commends Congress for Reaching Federal Spending Deal Dec 18, 2019

    On Monday, bipartisan leaders in the House and Senate reached an agreement on a $1.3 trillion federal spending deal for fiscal year 2020. The legislation package – which Congress is expected to pass and then submit to President Trump for signature this week – includes increased funding for vital public health agencies.

  • Encouraging Results Seen with Novel Approach to Gene Therapy for Sickle Cell Disease Dec 10, 2019

    Three adult patients with sickle cell disease (SCD) are doing well after receiving an infusion of their own stem cells that had been genetically engineered to induce them to stop producing harmful “sickle” hemoglobin and start producing a healthy form of hemoglobin, according to a study presented today during the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando.

1 of 46
back to top